Caprostat Injection
Marketer
Life Sciences Inc
Salt Composition
Epsilon Aminocaproic Acid (NA)
Overview Caprostat Injection
Hemostatic therapy with Caprostat Injection is indicated for hemorrhage management. Its application includes the prophylaxis of post-cardiotomy bleeding and the control of bleeding associated with thrombocytopenia (in aplastic anemia), hepatic cirrhosis, hematuria, and certain malignancies. Caprostat Injection achieves hemostasis by inhibiting clot lysis. Administration must be performed by a qualified healthcare provider; self-administration is contraindicated. Commonly reported adverse events include injection site reactions, myalgia, rhinorrhea, and fatigue. Persistent or worsening side effects should be promptly reported to your physician.
Uses of Caprostat Injection
Hemorrhage
Major Benefits of Caprostat Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Caprostat Injection:
- Nasal congestion (stuffy nose)
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Injection site reactions (pain, swelling, redness)
How to use Caprostat Injection:
Administering this medication will be handled by your physician or registered nurse; patient self-administration is strictly prohibited.
How Caprostat Injection works:
Caprostat Injection inhibits clot dissolution and thus controls hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Caprostat Injection may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Caprostat Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Caprostat Injection use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Caprostat Injection's effect on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should receive Caprostat Injection with careful monitoring. Dosage modification for Caprostat Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Caprostat Injection appears safe for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Caprostat Injection :
Omit any missed dose of Caprostat Injection and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Caprostat Injection
| Label | Value |
|---|---|
| Chemical Type | Medium-Chain Triglycerides |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Clot-stabilizing |
3,018 People bought this recently